Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 12/20 | 0.55 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL29029108 | 0.89 | ALOX5 (0.48) | ALOX5HTR2BHTR7GAAMEN1 | |
| SCHEMBL31174603 | 0.81 | ALOX5 (0.60) | ALOX5HTR2BHTR7GAANPSR1 | |
| SCHEMBL339368 | 0.81 | ALOX5 (0.60) | ALOX5HTR2BHTR7GAANPSR1 | |
| SCHEMBL10943406 | 0.77 | ALOX5 (0.42) | ALOX5HTR2BHTR7 | |
| SCHEMBL5847281 | 0.76 | ALOX5 (0.50) | ALOX5HTR2BHTR7GAANPSR1 | |
| SCHEMBL19971560 | 0.74 | ALOX5 (0.59) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL6310178 | 0.73 | ALOX5 (1.00) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL28844098 | 0.73 | ALOX5 (1.00) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL29355714 | 0.73 | ALOX5 (1.00) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL7862 | 0.73 | ALOX5 (1.00) | ALOX5HTR2BHTR7GAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539173-B | Four-electron bis-hydroxy phenazine derivative, and derivative, preparation method and application thereof | 内蒙古科技大学 | 2023-06-02 | — | — | CN | claimed |
| US-7659089-B2 | Chemical sensor enhanced by direct coupling of redox enzyme to conductive surface | UNIVERSITY OF WASHINGTON (US) | 2010-02-09 | — | — | US | claimed |
| US-20080153121-A1 | Chemical Sensor Enhanced by Direct Coupling of Redox Enzyme to Conductive Surface | UNIVERSITY OF WASHINGTON (US) | 2008-06-26 | — | — | US | claimed |
| US-7364886-B2 | Chemical sensor enhanced by direct coupling of redox enzyme to conductive surface | UNIVERSITY OF WASHINGTON (US) | 2008-04-29 | — | — | US | claimed |
| US-20070202559-A1 | Chemical sensor enhanced by direct coupling of redox enzyme to conductive surface | UNIVERSITY OF WASHINGTON | 2007-08-30 | — | — | US | claimed |
| US-20260085082-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | IMAGO BIOSCIENCES, INC. (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4637760-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | Imago Biosciences Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4559902-A2 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | Imago Biosciences Inc. (US) | 2025-05-28 | — | — | EP | disclosed |
| CN-119709943-A | Improved assay method | 中尺度技术有限责任公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20250032454-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | IMAGO BIOSCIENCES, INC. (US) | 2025-01-30 | — | — | US | disclosed |
| EP-3256218-B1 | A KDM1A INHIBITOR AND ITS USE IN THERAPY | IMAGO BIOSCIENCES INC (US) | 2024-12-11 | — | — | EP | disclosed |
| CN-112239774-B | Improved assay method | 中尺度技术有限责任公司 | 2024-12-03 | — | — | CN | disclosed |
| WO-2004011670-A2 | METHODS AND COMPOSITIONS FOR NAD(P)(H) OXIDASES | GEORGIA TECH RESEARCH CORPORATION (US) | 2004-02-05 | — | — | WO | disclosed |
| EP-1364043-A1 | METHODS AND KITS FOR IDENTIFYING SCAVENGERS OF REACTIVE OXYGEN SPECIES (ROS) | Pan, Shen Quan (SG) | 2003-11-26 | — | — | EP | disclosed |
| WO-2003050265-A2 | COMPOSITIONS AND METHODS FOR NORMALIZING ASSAYS | DIVERSA CORPORATION (US) | 2003-06-19 | — | — | WO | disclosed |
| WO-2002063032-A1 | METHODS AND KITS FOR IDENTIFYING SCAVENGERS OF REACTIVE OXYGEN SPECIES (ROS) | PAN SHEN QUAN (SG) | 2002-08-15 | — | — | WO | disclosed |
| US-20010020345-A1 | Gasoline additive for direct injection gasoline engine | NIPPON MITSUBISHI OIL CORPORATION | 2001-09-13 | — | — | US | disclosed |
| EP-1122295-A1 | GASOLINE ADDITIVE FOR DIRECT-INJECTION GASOLINE ENGINE | Nippon Mitsubishi Oil Corporation (JP) | 2001-08-08 | — | — | EP | disclosed |
| US-5928393-A | ESTERIFIED, ALKOXYLATED TERTIARY AMINE COMPOUND; DETERGENT ANTISLUDGE/ANTIDEPOSIT AGENT FOR INTERNAL COMBUSTION ENGINES | NIPPON OIL CO., LTD. (JP) | 1999-07-27 | — | — | US | disclosed |
| EP-0819753-A1 | Fuel additive | NIPPON OIL CO. LTD. (JP) | 1998-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085082-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | KDM1B, KDM1A, KDM5C | ALOX5 4522/4885HTR2B 2748/4885HTR7 2466/4885 |
| US-20250032454-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | KDM1B, KDM1A, KDM2A | ALOX5 4307/4885HTR2B 3273/4885HTR7 3593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.